- Early effects of tumor necrosis factor inhibition on bone homeostasis after soluble tumor necrosis factor receptor use
-
Lim MJ, Kwon SR, Joo K, Son MJ, Park SG, Park W
- KMID: 2070139
- Korean J Intern Med.
- 2014 Nov;29(6):807-813.
- doi: 10.3904/kjim.2014.29.6.807
BACKGROUND/AIMS: Our aim was to assess whether short-term treatment with soluble tumor necrosis factor (TNF) receptor affects circulating markers of bone metabolism in rheumatoid arthritis (RA) patients. METHODS: Thirty-three active RA... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Recommendations for Laboratory Testing and Use of Bone Turnover Markers in Management of Osteoporosis
-
Lee J, Vasikaran
- KMID: 1245249
- Ann Lab Med.
- 2012 Mar;32(2):105-112.
- doi: 10.3343/alm.2012.32.2.105
Osteoporosis is a major health problem worldwide, and is projected to increase exponentially due to the aging of the population. The absolute fracture risk in individual subjects is calculated by... -
- CITED
-
- Close
- SHARE
-
- Close
- The Skeletal Site-Differential Changes in Bone Mineral Density Following Bone Marrow Transplantation: 3-Year Prospective Study
-
Lee WY, Kang MI, Baek KH, Oh ES, Oh KW, Lee KW, Kim SW, Kim CC
- KMID: 648782
- J Korean Med Sci.
- 2002 Dec;17(6):749-754.
- doi: 10.3346/jkms.2002.17.6.749
Loss of bone mass is usually detected after bone marrow transplantation (BMT) during the early post-transplant period. However, little is known about the long-term effects of BMT on bone... -
- CITED
-
- Close
- SHARE
-
- Close
- Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis
-
Lim MJ, Kwon SR, Park SG, Park W
- KMID: 1785905
- J Korean Med Sci.
- 2010 Sep;25(9):1277-1283.
- doi: 10.3346/jkms.2010.25.9.1277
We investigated acute effects of intermittent large dose bisphophonate therapy in osteoporotic patients. Peripheral blood mononuclear cells were incubated with alendronate (100 micrometer) for 18 hr, in vitro and cytokine... -
- CITED
-
- Close
- SHARE
-
- Close
